British National Formulary. Lyme disease.

Cruickshank M, O’Flynn N, Faust S N. Lyme disease: summary of NICE guidance BMJ 2018; 361:k1261

Delong AK, Blossom B, Maloney EL et al. Antibiotic retreatment of Lyme disease in patients with persistent symptoms: a biostatistical review of randomized, placebo-controlled, clinical trials. Contemp Clin Trials. 2012 Nov;33(6):1132-42

Embers ME, Barthold SW, Borda JT et al. Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection. PLoS One. 2012;7(1):e29914

Fallon BA, Petkova E, Keilp JG, Britton CB. A reappraisal of the u.s. Clinical trials of post-treatment lyme disease syndrome. Open Neurol J. 2012;6:79-87

Kullberg B J, Vrijmoeth H D, van de Schoor F et al. Lyme borreliosis: diagnosis and management BMJ 2020; 369:m1041

Mavin S, Guntupalli  S, Robb M. Incidence and management of Lyme disease: a Scottish general practice retrospective study. BJGP Open 2024; 8 (3)

NHS Inform. Tick bites.

NICE. Lyme disease. [NG95] 2018.

NICE. Lyme disease. [QS186] 2019.

Rebman AW, Aucott JN. Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease. Front Med (Lausanne). 2020 Feb 25;7:57

UK Health Security Agency. Lyme disease: resources and guidance. 2014 (updated 2022).

UK Health Security Agency. Tips and tricks to stay safe from ticks. 2014.